Oxford Gene Technology Grants Microarray Licence to Febit
News Sep 21, 2005
Oxford Gene Technology (OGT) has announced that it has granted a microarray licence to febit biotech gmbh.
Dr Mike Evans, Chief Executive of OGT, said, “We are happy to support febit biotech’s technology by granting this licence and thus further the use of microarray technology”.
Peer Stähler, CSO of febit biotech gmbh said, “The agreement with OGT strengthens our IP and places us in a position to successfully market Geniom® worldwide”.
The acquired licence refers to the “Southern array patents”, fundamental patents covering the manufacture and use of DNA microarrays, and will remain valid for the patents’ lifetime.
As the world struggles to meet the increasing demand for energy, coupled with the rising levels of CO2 in the atmosphere from deforestation and the use of fossil fuels, photosynthesis in nature simply cannot keep up with the carbon cycle. In a recent paper, researchers report significant progress in optimizing systems that mimic the first stage of photosynthesis, capturing and harnessing light energy from the sun.